U.S. Other Utilities Stock News

Wondering if Citizens Financial Group at around US$64.41 is still offering value after a strong run, or if most of the opportunity is already priced in. The stock has seen a 0.9% decline over the last 7 days, a 12.8% return over 30 days, 8.5% year to date, 88.3% over 1 year and 83.9% over 5 years, which points to meaningful shifts in how the market is viewing the bank. Recent coverage has focused on Citizens Financial Group as part of broader discussions around U.S. bank stocks, capital...

Why Corcept Therapeutics (CORT) Is Back on Investors’ Radar Corcept Therapeutics (CORT) has drawn fresh attention after presenting final overall survival data from its pivotal Phase 3 ROSELLA trial and securing FDA approval for Lifyorli in platinum-resistant ovarian cancer. See our latest analysis for Corcept Therapeutics. The recent FDA approval of Lifyorli and its inclusion in NCCN guidelines appear to have coincided with strong momentum, with a 31.2% 1 month share price return and a 26.6%...

Ionis Pharmaceuticals: Recent Returns and Business Profile Ionis Pharmaceuticals (IONS) has seen mixed recent returns, with the stock showing a small decline over the past week and gains over the past month. Year to date, performance remains slightly negative. Over the past year, Ionis has delivered a 1.65% total return, with longer horizons showing higher cumulative figures over the past 3 years and past 5 years. The company last closed at US$75.26, giving it a market value of about...

In recent days, GigaCloud Technology Inc. has attracted fresh attention after Jim Cramer praised the company on Mad Money, highlighting his positive meeting with the CEO and describing the stock as inexpensive, while Zacks assigned it a top rating supported by upbeat earnings estimate revisions. This combination of high-profile media endorsement and favorable analyst sentiment is drawing new focus to GigaCloud’s B2B ecommerce platform for large-parcel cross-border trade. Now, we’ll examine...

Mondelez International (MDLZ) is in focus after releasing its 2025 sustainability progress report and highlighting work with Celleste Bio on cell cultured cocoa butter, alongside fresh shareholder pressure on plastics packaging and board leadership. See our latest analysis for Mondelez International. At a share price of US$57.07, Mondelez has seen a 6.37% year to date share price return, while its 1 year total shareholder return of 12.40% and 3 year total shareholder return of 12.63% indicate...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Investors may be wondering whether Chevron, at around US$188 per share, still offers value or if most of the easy gains are already behind it. The stock has recorded a 20.7% return year to date and a 42.6% return over the last year, alongside shorter term moves such as a 1.2% decline over 7 days and a 5.0% decline over 30 days. These recent moves sit against an ongoing flow of company and industry updates that continue to shape expectations around energy prices, long term capital spending,...

If you are wondering whether Doximity's current share price still reflects its long term potential, the recent moves in the stock make a closer look at value hard to ignore. The stock last closed at US$24.25, with a 14.6% gain over the past 7 days, a 2.6% decline over 30 days, and year to date and 1 year returns of 44.0% and 54.4% declines respectively. These swings have kept attention on how the market is reassessing expectations for Doximity, with recent headlines continuing to frame the...

Vertical Aerospace (NYSE:EVTL) has drawn fresh attention after completing a two-way piloted transition flight in its full-scale tiltrotor eVTOL. This is a key step that validates its electric air taxi concept under civil aviation oversight. See our latest analysis for Vertical Aerospace. The successful transition flight has arrived alongside sharp short term share price momentum, with a 1 day share price return of 25.56% and 7 day return of 45.22%. However, this sits against a weaker 90 day...

Wondering if Adams Diversified Equity Fund is still good value after its recent run, or if you might be late to the story? The share price last closed at US$23.79, with returns of 1.1% over 7 days, 4.7% over 30 days, 2.3% year to date, 42.5% over 1 year, 104.2% over 3 years and 109.8% over 5 years. Recent coverage has focused on how Adams Diversified Equity Fund fits into the broader Capital Markets space and what that means for investors weighing income, diversification and liquidity. This...

Clearway Energy is asking stockholders to approve a plan to consolidate its public share classes into a single share class. The company is seeking this approval at an upcoming stockholder meeting as part of an effort to simplify its equity structure. Proxy advisory firm ISS has recommended that investors vote "FOR" the proposed share class unification. For investors tracking NYSE:CWEN.A, the proposal comes as Clearway Energy trades at a share price of $39.98 and carries a value score of 3...

LyondellBasell Industries recently drew attention as Jim Cramer highlighted it in a list of companies linked to the Iran conflict, while Citigroup reiterated a positive analyst stance, and the company also published its 2025 Sustainability Report detailing operational performance and safety outcomes. The report underscored LyondellBasell’s progress in circular and low‑carbon polymers, including ongoing construction of its first commercial‑scale catalytic chemical recycling facility in...

RBC Capital Markets’ decision to lift its 2026 funds from operations estimate for American Healthcare REIT (AHR) to US$2.04 per share, tied to a higher investment pace, has put fresh attention on the stock. See our latest analysis for American Healthcare REIT. The latest analyst revision comes as American Healthcare REIT trades at US$50.58, with a 1-day share price return of 2.22% and a 7-day share price return of 2.99%. The 1-year total shareholder return of 69.18% points to strong momentum...

If you are wondering whether Palo Alto Networks is fairly priced or if the market is missing something, starting with a clear view of its current valuation can help ground your decision. The stock last closed at US$166.97, with returns of around 0% over 7 days, a 1.3% decline over 30 days, a 6.9% decline year to date, and a 0.4% decline over the past year. The 3 year and 5 year returns stand at 73.7% and 184.0% respectively. Recent headlines around Palo Alto Networks have focused on its role...

In early April 2026, the American Hospital Association named Rubrik a Preferred Cybersecurity Provider, giving nearly 5,000 member hospitals access to its cyber resilience bundle, including identity recovery, Microsoft 365 protection, ransomware training, and a five-year financial impact assessment. This endorsement strengthens Rubrik’s role in safeguarding critical healthcare infrastructure, tying its data security platform directly to operational continuity for hospitals facing rising...

Wondering if Nabors Industries at around US$82.24 is priced for its risks or offering genuine value? This article focuses squarely on what the current share price could mean for you. The stock is roughly flat over the last week with a 0.8% decline, but is up 3.0% over 30 days and 48.4% year to date, while the 1 year return sits at 166.1% against weaker 3 year and 5 year returns of 28.3% and 1.3% declines. Recent trading interest reflects how investors are reassessing Nabors Industries after...

Exelixis (EXEL) is drawing attention after recent trading, with shares last closing at $44.38. For investors, the key questions now center on how the company’s current valuation lines up with its fundamentals. See our latest analysis for Exelixis. While the 7 day share price return of 2.27% is soft, a 30 day share price return of 6.10% alongside a 1 year total shareholder return of 22.63% points to momentum that has built over a longer horizon. If you want to see how other cancer and biotech...

Wondering if Sempra at around US$95.79 is priced for opportunity or already reflects its strengths? This article unpacks what the current share price might be saying about value. The stock has had a mixed recent run, with a 4.0% decline over the last 7 days and a 0.2% decline over 30 days, but a 6.8% gain year to date and 38.8% over 1 year, alongside 34.3% over 3 years and 63.2% over 5 years. Recent coverage of Sempra has focused on its role in the US utilities sector and how investors are...

Event context and recent stock move Strategy (MSTR) has recently attracted attention after a 3.8% one-day gain and a 15.8% move over the past week, prompting investors to reassess how its bitcoin treasury focus and software operations fit into their portfolios. See our latest analysis for Strategy. This recent 15.8% 7 day share price return comes after a weaker patch, with a 90 day share price decline of 14.3%, while the 3 year total shareholder return remains very large. If you are watching...

If you are wondering whether Walmart's share price still offers value after a long run, or if you might be late to the story, this article breaks down what the current valuation suggests about the stock. Walmart's shares most recently closed at US$124.82, with returns of 10.7% year to date and 35.1% over the last year, even after a 3.3% decline over the past week and a 0.2% slip over the last month. Recent headlines around Walmart have focused on its role as a major consumer retailer,...

Why Bristol-Myers Squibb is Back on Investors’ Radar Bristol-Myers Squibb (BMY) is drawing fresh attention after recent trading left the stock at a last close of US$58.96, with a mixed pattern across short term and longer term returns. See our latest analysis for Bristol-Myers Squibb. Recent trading has been choppy, with a 1-day share price return of 1.85% contrasting with softer 7-day and 30-day share price returns. The 1-year total shareholder return of 25.75% points to momentum that has...

ACM Research (ACMR) is coming into focus as investors look ahead to its preliminary first quarter 2026 revenue update on April 27 and assess the recent ACM Planetary Family product portfolio rebranding. See our latest analysis for ACM Research. The share price, now at US$47.89, has seen a 6.71% year to date share price return and a very large 3 year total shareholder return of 339.76%. This suggests that momentum may be influenced by recent product rebranding and the upcoming revenue...

Why Stanley Black & Decker Stock Is Back on Investors’ Radar Stanley Black & Decker (SWK) has attracted fresh attention after recent share price moves, with the stock up about 2% over the past day but showing declines over the past week and month. See our latest analysis for Stanley Black & Decker. That 1.92% 1 day share price return comes after a 6.75% 7 day and 19.08% 90 day share price decline, while the 1 year total shareholder return of 25.42% contrasts with a 5 year total shareholder...

Bank of America (NYSE:BAC) reports its strongest quarterly results in nearly two decades for Q1 2026. Earnings per share are 25% higher year-over-year, with revenue growth of 7%. Equities trading reaches record levels, alongside double digit gains in investment banking and wealth management. Management highlights AI driven tools, including Meeting Journey AI, as material contributors to performance and efficiency. For a large universal bank like Bank of America, these Q1 2026 results show...